{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+medication+%2B+placebo+alcohol&page=11", "query": { "intervention": "placebo medication + placebo alcohol", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 415, "total_pages": 42, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+medication+%2B+placebo+alcohol&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+medication+%2B+placebo+alcohol&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T10:55:40.808Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00759317", "title": "Physiologic Monitoring of Antidepressant Treatment Response", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Depression" ], "interventions": [ { "name": "venlafaxine (Effexor)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 37, "start_date": "2001-06", "completion_date": "2002-09", "has_results": false, "last_update_posted_date": "2014-07-03", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00759317" }, { "nct_id": "NCT02104414", "title": "Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hemorrhoid" ], "interventions": [ { "name": "Exparel", "type": "DRUG" }, { "name": "Bupivacaine HCl with Epinephrine", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Luke's-Roosevelt Hospital Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 11, "start_date": "2014-04", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2018-12-04", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02104414" }, { "nct_id": "NCT00634829", "title": "Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma", "Bronchospasm" ], "interventions": [ { "name": "albuterol (Armstrong Albuterol HFA)", "type": "DRUG" }, { "name": "Albuterol Sulfate (Provenetil-HFA)", "type": "DRUG" }, { "name": "Placebo-HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "12 Years to 50 Years" }, "enrollment_count": 24, "start_date": "2008-02", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2013-07-15", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 3, "location_summary": "Denver, Colorado • Englewood, Colorado • Lakewood, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00634829" }, { "nct_id": "NCT00576069", "title": "Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "fluticasone/salmeterol", "type": "DRUG" }, { "name": "mometasone/formoterol", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "10 Years to 95 Years" }, "enrollment_count": 60, "start_date": "2007-10-25", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00576069" }, { "nct_id": "NCT04713657", "title": "Beta-blocker Administration for Cardiomyocyte Division", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Tetralogy of Fallot", "Double Outlet Right Ventricle" ], "interventions": [ { "name": "N-thymidine", "type": "OTHER" }, { "name": "Urine Collection", "type": "OTHER" }, { "name": "Echocardiogram", "type": "PROCEDURE" }, { "name": "Cardiac MRI (CMR)", "type": "PROCEDURE" }, { "name": "Propranolol Hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Physical Exam", "type": "PROCEDURE" }, { "name": "Specimen Collection", "type": "OTHER" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Days", "maximum_age": "60 Days", "sex": "ALL", "summary": "30 Days to 60 Days" }, "enrollment_count": 40, "start_date": "2022-12-16", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2025-11-18", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 3, "location_summary": "New York, New York • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04713657" }, { "nct_id": "NCT03478696", "title": "A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match budesonide/formoterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" }, { "name": "HandiHaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 732, "start_date": "2018-06-25", "completion_date": "2019-03-18", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 42, "location_summary": "Mobile, Alabama • Bakersfield, California • Sacramento, California + 35 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478696" }, { "nct_id": "NCT03970109", "title": "HLAB-002 of ANS-6637 for Alcohol Use Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Use Disorder" ], "interventions": [ { "name": "ANS-6637", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 43, "start_date": "2019-10-08", "completion_date": "2020-05-22", "has_results": true, "last_update_posted_date": "2024-10-29", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 3, "location_summary": "New Haven, Connecticut • Providence, Rhode Island • Charleston, South Carolina", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Providence", "state": "Rhode Island" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03970109" }, { "nct_id": "NCT05656534", "title": "Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alcohol Use Disorder" ], "interventions": [ { "name": "Suvorexant", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 81, "start_date": "2022-11-29", "completion_date": "2024-08-01", "has_results": true, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05656534" }, { "nct_id": "NCT05839652", "title": "Treatment of Orthostatic Hypotension in SCI", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypotension" ], "interventions": [ { "name": "Midodrine Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "James J. Peters Veterans Affairs Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 25, "start_date": "2023-07-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 2, "location_summary": "West Orange, New Jersey • The Bronx, New York", "locations": [ { "city": "West Orange", "state": "New Jersey" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05839652" }, { "nct_id": "NCT01576718", "title": "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "OTHER" }, { "name": "Flovent Diskus", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 889, "start_date": "2012-04", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2018-05-08", "last_synced_at": "2026-10-15T10:55:40.808Z", "location_count": 148, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Goodyear, Arizona + 114 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01576718" } ] }